MedPath

Impact of Asthma Treatments on Daily Activities

Conditions
Asthma
Allergies
Registration Number
NCT00350376
Lead Sponsor
Ovation Research Group
Brief Summary

The primary objective of this web-based, cross-sectional study is to assess and compare the ability to sleep, work or go to school, and to participate in leisure activities among subjects who are receiving Xolair treatment and subjects who were eligible to receive Xolair, but instead have been using Advair for at least 1 year.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1500
Inclusion Criteria
  • Have asthma and allergies
  • Currently taking Xolair® or Advair®
  • Started Xolair® treatment within the last 4 to 12 months OR have been taking Advair® for at least 12 months
  • Between 18 and 55 years of age
  • A non-smoker for at least 6 months
  • Have internet access
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ovation Research Group

🇺🇸

San Francisco, California, United States

Ovation Research Group
🇺🇸San Francisco, California, United States
Susan D Mathias, MPH
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.